
A “maturity curve” can help organizations move engagement beyond performative gestures to a strategic asset.

A strategic advisor to visionary leaders in the life sciences. As Principal and CEO of Luminous, she helps innovators bridge the gap between lab and life. Too often, promising biomedical innovations fail to perform as expected in the market—not because they lack efficacy, but because they overlook the realities of patients’ lives. Noël helps companies address this gap by surfacing patient voices and revealing insights that highlight lived experiences.

A “maturity curve” can help organizations move engagement beyond performative gestures to a strategic asset.